ORIENTBIO Inc. Logo

ORIENTBIO Inc.

Provides animal models & technical services for preclinical R&D to pharma & research institutions.

002630 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기 성남시 중원구 상대원동 143-1, 성남시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ORIENTBIO Inc. is a biotechnology company specializing in the production and distribution of laboratory animal models for preclinical research. The company supplies a range of species, including mice and rats, to pharmaceutical companies, universities, and other research institutions. In addition to its core offering of animal models, ORIENTBIO provides related technical services such as genetic testing and molecular biological analysis to support life sciences research and development. The company operates AAALAC-accredited facilities, underscoring its commitment to high standards of animal welfare and care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Quarterly Report
분기보고서 (2025.06)
Korean 882.1 KB
2025-06-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.4 KB
2025-06-19 00:00
Audit Report / Information
감사보고서제출
Korean 11.2 KB
2025-06-19 00:00
Annual Report
사업보고서 (2025.03)
Korean 1.3 MB
2025-06-19 00:00
Earnings Release
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 19.8 KB
2025-06-13 00:00
Audit Report / Information
[기재정정]감사보고서제출
Korean 29.5 KB
2025-06-13 00:00
Audit Report / Information
[기재정정]사업보고서 (2019.03)
Korean 463.2 KB
2025-06-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 128.0 KB
2025-06-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.3 KB
2025-05-13 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 11.5 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 3.9 KB
2025-02-14 00:00
Quarterly Report
분기보고서 (2024.12)
Korean 905.3 KB
2025-01-10 00:00
Regulatory News Service
조회공시요구(현저한시황변동)에대한답변(중요공시대상없음)
Korean 5.4 KB

Automate Your Workflow. Get a real-time feed of all ORIENTBIO Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ORIENTBIO Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.